Skip to main content

Advertisement

SpringerLink
Log in

Cypermethrin-Induced Nigrostriatal Dopaminergic Neurodegeneration Alters the Mitochondrial Function:A Proteomics Study

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Cypermethrin induces the slow and progressive degeneration of the nigrostriatal dopaminergic neurons in rats. Postnatal preexposure with low doses of cypermethrin is known to enhance the susceptibility of animals upon adulthood reexposure. The study was undertaken to delineate the role of mitochondria in cypermethrin-induced neurodegeneration. Indexes of dopaminergic neurodegeneration, microglial activation, and mitochondrial dysfunction and its proteome profile were assessed in controls and cypermethrin-treated rats. Cypermethrin increased nigral dopaminergic neurodegeneration and microglial activation while reduced mitochondrial membrane potential and complex I activity. Cypermethrin attenuated striatal dopamine content and differentially regulated the expressions of the nine striatal and ten nigral proteins. Western blot analyses showed that cypermethrin also increased c-Jun N-terminal kinase (JNK), caspase-3, tumor suppressor protein (p53), tumor necrosis factor-α (TNF-α), p38 mitogen-activated protein kinase (p38 MAPK), and heme oxygenase-1 (HO-1) expressions and reduced B cell lymphoma-2 protein (Bcl-2) expression. Syndopa and minocycline rescued from cypermethrin induced augmentation in microglial activation and reductions in mitochondrial membrane potential and complex I activity, striatal dopamine content, and degeneration of nigral dopaminergic neurons. Syndopa and minocycline, respectively, modulated the expressions of four and six striatal and four and seven nigral proteins. Furthermore, they reinstated the expressions of JNK, caspase-3, Bcl-2, p53, p38 MAPK, TNF-α, and HO-1. The study demonstrates that cypermethrin induces mitochondrial dysfunction and alters mitochondrial proteome leading to oxidative stress and apoptosis, which regulate the nigrostriatal dopaminergic neurodegeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Yadav S, Dixit A, Agrawal S, Singh A, Srivastava G, Singh AK, Srivastava PK, Prakash O, Singh MP (2012) Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson’s disease pathogenesis. Mol Neurobiol 46:495–512

    Article  CAS  PubMed  Google Scholar 

  2. Singh AK, Tiwari MN, Upadhyay G, Patel DK, Singh D, Prakash O, Singh MP (2012) Long-term exposure to cypermethrin induces the nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood. Neurobiol Aging 33:404–415

    Article  CAS  PubMed  Google Scholar 

  3. Tiwari MN, Singh AK, Ahmed I, Upadhyay G, Singh D, Patel DK, Singh C, Prakash O, Singh MP (2010) Effects of cypermethrin on monoamine transporters, xenobiotic metabolizing enzymes and lipid peroxidation in the rat nigrostriatal system. Free Radic Res 44:1416–1424

    Article  CAS  PubMed  Google Scholar 

  4. Singh AK, Tiwari MN, Dixit A, Upadhyay G, Patel DK, Singh D, Prakash O, Singh MP (2011) Nigrostriatal proteomics of cypermethrin-induced dopaminergic neurodegeneration microglial activation dependent and independent regulations. Toxicol Sci 122:526–538

    Article  CAS  PubMed  Google Scholar 

  5. Autere J, Moilanen JS, Finnilä S, Soininen H, Mannermaa A, Hartikainen P, Hallikainen M, Majamaa K (2004) Mitochondrial DNA polymorphisms as risk factors for Parkinson’s disease and Parkinson’s disease dementia. Hum Genet 115:29–35

    Article  CAS  PubMed  Google Scholar 

  6. Andrews ZB, Horvath B, Barnstable CJ, Elsworth J, Yang L, Beal MF, Roth RH, Matthews RT, Horvath TL (2005) Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson’s disease. J Neurosci 25:184–191

    Article  CAS  PubMed  Google Scholar 

  7. Pennington K, Peng J, Hung CC, Banks RE, Robinson PA (2010) Differential effects of wild-type and A53T mutant isoform of alpha-synuclein on the mitochondrial proteome of differentiated SH-SY5Y cells. J Proteome Res 9:2390–2401

    Article  CAS  PubMed  Google Scholar 

  8. Johnson MD, Yu LR, Corads TP, Kinoshita Y, Uo T, McBee JK, Veenstra TD, Morrison RS (2005) The proteomics of neurodegeneration. Am J Pharmacogenom 5:259–270

    Article  CAS  Google Scholar 

  9. Patel S, Sinha A, Singh MP (2007) Identification of differentially expressed proteins in striatum of maneb-and paraquat-induced Parkinson’s disease phenotype in mouse. Neurotoxicol Teratol 29:578–585

    Article  CAS  PubMed  Google Scholar 

  10. Chen X, Li J, Hou J, Xie Z, Yang F (2010) Mammalian mitochondrial proteomics: insights into mitochondrial functions and mitochondria-related diseases. Expert Rev Proteomics 7:333–345

    Article  CAS  PubMed  Google Scholar 

  11. Dixit A, Srivastava G, Verma D, Mishra M, Singh PK, Prakash O, Singh MP (2013) Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson’s disease. Biochim Biophys Acta 1832:1227–1240

    Article  CAS  PubMed  Google Scholar 

  12. Huang CL, Lee YC, Yang YC, Kuo TY, Huang NK (2012) Minocycline prevents paraquat-induced cell death through attenuating endoplasmic reticulum stress and mitochondrial dysfunction. Toxicol Lett 209:203–210

    Article  CAS  PubMed  Google Scholar 

  13. Jung BD, Shin EJ, Nguyen XK, Jin CH, Bach JH, Park SJ, Nah SY, Wie MB, Bing G, Kim HC (2010) Potentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration. Neurochem Int 56:229–244

    Article  CAS  PubMed  Google Scholar 

  14. Shin JY, Park HJ, Ahn YH, Lee PH (2009) Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson’s disease: a direct comparison study. J Neurochem 111:1042–1050

    Article  CAS  PubMed  Google Scholar 

  15. Tomás-Camardiel M, Rite I, Herrera AJ, de Pablos RM, Cano J, Machado A, Venero JL (2004) Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood–brain barrier, and damage in the nigral dopaminergic system. Neurobiol Dis 16:190–201

    Article  PubMed  Google Scholar 

  16. Ciesielska A, Mittermeyer G, Hadaczek P, Kells AP, Forsayeth J, Bankiewicz KS (2011) Anterograde axonal transport of AAV2-GDNF in rat basal ganglia. Mol Ther 19:922–927

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic, Sydney, New York

    Google Scholar 

  18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    CAS  PubMed  Google Scholar 

  19. Burté F, De Girolamo LA, Hargreaves AJ, Billett EE (2011) Alterations in the mitochondrial proteome of neuroblastoma cells in response to complex 1 inhibition. J Proteome Res 10:1974–1986

    Article  PubMed  Google Scholar 

  20. Morrison RS, Kinoshita Y, Johnson MD, Uo T, Ho JT, McBee JK, Conrads TP, Veenstra TD (2002) Proteomic analysis in the neurosciences. Mol Cell Proteomics 1:553–560

    Article  CAS  PubMed  Google Scholar 

  21. Song Z, Guo Q, Zhang J, Li M, Liu C, Zou W (2012) Proteomic analysis of PKCγ-related proteins in the spinal cord of morphine-tolerant rats. PLoS One 7:e42068

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Grunert T, Leitner NR, Marchetti-Deschmann M, Miller I, Wallner B, Radwan M, Vogl C, Kolbe T, Kratky D, Gemeiner M, Allmaier G, Müller M, Strobl BA (2011) Comparative proteome analysis links tyrosine kinase 2 (Tyk2) to the regulation of cellular glucose and lipid metabolism in response to poly (I:C). J Proteomics 74:2866–2880

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Hirano M, Rakwal R, Shibato J, Sawa H, Nagashima K, Ogawa Y, Yoshida Y, Iwahashi H, Niki E, Masuo Y (2008) Proteomics- and transcriptomics-based screening of differentially expressed proteins and genes in brain of Wig rat: a model for attention deficit hyperactivity disorder (ADHD) research. J Proteome Res 7:2471–2489

    Article  CAS  PubMed  Google Scholar 

  24. Lessner G, Schmitt O, Haas SJ, Mikkat S, Kreutzer M, Wree A, Glocker MO (2010) Differential proteome of the striatum from hemiparkinsonian rats displays vivid structural remodeling processes. J Proteome Res 9:4671–4687

    Article  CAS  PubMed  Google Scholar 

  25. Sinha A, Srivastava N, Singh S, Singh AK, Bhushan S, Shukla R, Singh MP (2009) Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson’s disease patients: a proteomic approach. Clin Chim Acta 400:14–20

    Article  CAS  PubMed  Google Scholar 

  26. Shaw J, Rowlinson R, Nickson J, Stone T, Sweet A, Williams K, Tonge R (2003) Evaluation of saturation labelling two-dimensional difference gel electrophoresis fluorescent dyes. Proteomics 3:1181–1195

    Article  CAS  PubMed  Google Scholar 

  27. Banerjee K, Sinha M, Pham CL, Jana S, Chanda D, Cappai R, Chakrabarti S (2010) α-Synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson’s disease. FEBS Lett 584:1571–1576

    Article  CAS  PubMed  Google Scholar 

  28. Krahenbuhl S, Chang M, Brass EP, Hoppel CL (1991) Decreased activities of ubiquinol:ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c:oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin [c-lactam]-induced methylmalonic aciduria. J Biol Chem 266:20998–21003

    CAS  PubMed  Google Scholar 

  29. Shults CW, Nasirian F, Ward DM, Nakano K, Pay M, Hill LR, Haas RH (1995) Carbidopa/levodopa and selegiline do not affect platelet mitochondrial function in early Parkinsonism. Neurology 45:344–348

    Article  CAS  PubMed  Google Scholar 

  30. Srivastava G, Dixit A, Yadav S, Patel DK, Prakash O, Singh MP (2012) Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse. Free Radic Biol Med 52:1294–1306

    Article  CAS  PubMed  Google Scholar 

  31. Tiwari MN, Singh AK, Agrawal S, Gupta SP, Jyoti A, Shanker R, Prakash O, Singh MP (2012) Cypermethrin alters the expression profile of mRNAs in the adult rat striatum: a putative mechanism of postnatal pre-exposure followed by adulthood re-exposure-enhanced neurodegeneration. Neurotox Res 22:321–334

    Article  CAS  PubMed  Google Scholar 

  32. Patel S, Singh K, Singh S, Singh MP (2008) Gene expression profiles of mouse striatum in control and maneb + paraquat-induced Parkinson’s disease phenotype: validation of differentially expressed energy metabolizing transcripts. Mol Biotechnol 40:59–68

    Article  CAS  PubMed  Google Scholar 

  33. Li CY, Lee JS, Ko YG, Kim JI, Seo JS (2000) Heat shock protein 70 inhibits apoptosis downstream of cytochrome c release and upstream of caspase-3 activation. J Biol Chem 275:25665–25671

    Article  CAS  PubMed  Google Scholar 

  34. Fontanesi F, Soto IC, Horn D, Barrientos A (2006) Assembly of mitochondrial cytochrome c-oxidase, a complicated and highly regulated cellular process. Am J Physiol Cell Physiol 291:C1129–C1147

    Article  CAS  PubMed  Google Scholar 

  35. Diedrich M, Mao L, Bernreuther C, Zabel C, Nebrich G, Kleene R, Klose J (2008) Proteome analysis of ventral midbrain in MPTP-treated normal and L1cam transgenic mice. Proteomics 8:1266–1275

    Article  CAS  PubMed  Google Scholar 

  36. Okado-Matsumoto A, Fridovich I (2001) Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu, Zn-SOD in mitochondria. J Biol Chem 276:38388–38393

    Article  CAS  PubMed  Google Scholar 

  37. Troy CM, Derossi D, Prochiantz A, Greene LA, Shelanski ML (1996) Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway. J Neurosci 16:253–261

    CAS  PubMed  Google Scholar 

  38. Krapfenbauer K, Engidawork E, Cairns N, Fountoulakis M, Lubec G (2003) Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res 967:152–160

    Article  CAS  PubMed  Google Scholar 

  39. Lee W, Choi KS, Riddell J, Ip C, Ghosh D, Park JH, Park YM (2007) Human peroxiredoxin 1 and 2 are not duplicate proteins: the unique presence of CYS83 in Prx1 underscores the structural and functional differences between Prx1 and Prx2. J Biol Chem 282:22011–22022

    Article  CAS  PubMed  Google Scholar 

  40. Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, Shen J (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 279:18614–18622

    Article  CAS  PubMed  Google Scholar 

  41. Garbis S, Lubec G, Fountoulakis M (2005) Limitations of current proteomics technologies. J Chromatogr A 1077:1–18

    Article  CAS  PubMed  Google Scholar 

  42. Knight M, Raghavan N, Goodall C, Cousin C, Ittiprasert W, Sayed A, Miller A, Williams DL, Bayne CJ (2009) Biomphalaria glabrata peroxiredoxin: effect of Schistosoma mansoni infection on differential gene regulation. Mol Biochem Parasitol 167:20–31

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  43. Ferrer I, Perez E, Dalfó E, Barrachina M (2007) Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson’s disease. Neurosci Lett 415:205–209

    Article  CAS  PubMed  Google Scholar 

  44. Park B, Yang J, Yun N, Choe KM, Jin BK, Oh YJ (2010) Proteomic analysis of expression and protein interactions in a 6-hydroxydopamine-induced rat brain lesion model. Neurochem Int 57:16–32

    Article  CAS  PubMed  Google Scholar 

  45. Periquet M, Corti O, Jacquier S, Brice A (2005) Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. J Neurochem 95:1259–1276

    Article  CAS  PubMed  Google Scholar 

  46. Krishnan KS, Rikhy R, Rao S, Shivalkar M, Mosko M, Narayanan R, Etter P, Estes PS, Ramaswami M (2001) Nucleoside diphosphate kinase, a source of GTP, is required for dynamin-dependent synaptic vesicle recycling. Neuron 30:197–210

    Article  CAS  PubMed  Google Scholar 

  47. Carré M, André N, Carles G, Borghi H, Brichese L, Briand C, Braguer D (2002) Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel. J Biol Chem 277:33664–33669

    Article  PubMed  Google Scholar 

  48. Chaturvedi V, Jonnala KU, Cherukuvada VBS, Rangaraj N, Gunda S, Rathinam K, Singh S, Amere SS (2011) Repercussion of mitochondria deformity induced by anti-Hsp90 Drug 17AAG in human tumor cells. Drug Target Insights 5:11–32

    CAS  Google Scholar 

  49. Lopez-Campistrous A, Hao L, Xiang W, Ton D, Semchuk P, Sander J, Ellison MJ, Fernandez-Patron C (2008) Mitochondrial dysfunction in the hypertensive rat brain: respiratory complexes exhibit assembly defects in hypertension. Hypertension 51:412–419

    Article  CAS  PubMed  Google Scholar 

  50. Lubec G, Afjehi-Sadat L, Yang JW, John JP (2005) Searching for hypothetical proteins: theory and practice based upon original data and literature. Prog Neurobiol 77:90–127

    Article  CAS  PubMed  Google Scholar 

  51. Perrot A, Pionneau C, Azar N, Baillou C, Lemoine FM, Leblond V, Merle-Béral H, Béné MC, Herbrecht R, Bahram S, Vallat L (2012) Waldenström’s macroglobulinemia harbors a unique proteome where Ku70 is severely underexpressed as compared with other B-lymphoproliferative disorders. Blood Cancer J 2:e88

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  52. Paasch U, Heidenreich F, Pursche T, Kuhlisch E, Kettner K, Grunewald S, Kratzsch J, Dittmar G, Glander HJ, Hoflack B, Kriegel TM (2011) Identification of increased amounts of eppin protein complex components in sperm cells of diabetic and obese individuals by difference gel electrophoresis. Mol Cell Proteomics 10:M110.007187

    Article  PubMed Central  PubMed  Google Scholar 

  53. Person MD, Shen J, Traner A, Hensley SC, Lo HH, Abbruzzese LJ, Li D (2006) Protein fragment domains identified using 2D Gel electrophoresis/MALDI-TOF. J Biomol Tech 17:145–156

    PubMed Central  PubMed  Google Scholar 

  54. Baldwin MA (2004) Protein identification by mass spectrometry: issues to be considered. Mol Cell Proteomics 3:1–9

    Article  CAS  PubMed  Google Scholar 

  55. Rinalducci S, Murgiano L, Zolla L (2008) Redox proteomics: basic principles and future perspectives for the detection of protein oxidation in plants. J Exp Bot 59:3781–3801

    Article  CAS  PubMed  Google Scholar 

  56. Spencer JP, Jenner A, Butler J, Aruoma OI, Dexter DT, Jenner P, Halliwell B (1996) Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson’s disease. Free Radic Res 24:95–105

    Article  CAS  PubMed  Google Scholar 

  57. O’Sullivan SS, Johnson M, Williams DR, Revesz T, Holton JL, Lees AJ, Perry EK (2011) The effect of drug treatment on neurogenesis in Parkinson’s disease. Mov Disord 26:45–50

    Article  PubMed  Google Scholar 

  58. Good CH, Hoffman AF, Hoffer BJ, Chefer VI, Shippenberg TS, Bäckman CM, Larsson NG, Olson L, Gellhaar S, Galter D, Lupica CR (2011) Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson’s disease. FASEB J 25:1333–1344

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  59. Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O (2003) Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci USA 100:13632–13637

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  60. Noble W, Garwood CJ, Hanger DP (2009) Minocycline as a potential therapeutic agent in neurodegenerative disorders characterised by protein misfolding. Prion 3:78–83

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  61. Gassner B, Wüthrich A, Scholtysik G, Solioz M (1997) The pyrethroids permethrin and cyhalothrin are potent inhibitors of the mitochondrial complex I. J Pharmacol Exp Ther 281:855–860

    CAS  PubMed  Google Scholar 

  62. Bagh MB, Thakurta IG, Biswas M, Behera P, Chakrabarti S (2011) Age-related oxidative decline of mitochondrial functions in rat brain is prevented by long term oral antioxidant supplementation. Biogerontology 12:119–131

    Article  CAS  PubMed  Google Scholar 

  63. Nakai M, Mori A, Watanabe A, Mitsumoto Y (2003) 1-methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum. Exp Neurol 179:103–110

    Article  CAS  PubMed  Google Scholar 

  64. Gevaerd MS, Miyoshi E, Silveira R, Canteras NS, Takahashi RN, Da Cunha C (2001) L-Dopa restores striatal dopamine level but fails to reverse MPTP-induced memory deficits in rats. Int J Neuropsychopharmacol 4:361–370

    Article  CAS  PubMed  Google Scholar 

  65. Won H, Lim S, Jang M, Kim Y, Rashid MA, Jyothi KR, Dashdorj A, Kang I, Ha J, Kim SS (2012) Peroxiredoxin-2 upregulated by NF-κB attenuates oxidative stress during the differentiation of muscle-derived C2C12 cells. Antioxid Redox Signal 16:245–261

    Article  CAS  PubMed  Google Scholar 

  66. Burgula S, Medisetty R, Jammulamadaka N, Musturi S, Ilavazhagan G, Singh SS (2010) Downregulation of PEBP1 in rat brain cortex in hypoxia. J Mol Neurosci 41:36–47

    Article  CAS  PubMed  Google Scholar 

  67. Zhou P, Qian L, D’Aurelio M, Cho S, Wang G, Manfredi G, Pickel V, Iadecola C (2012) Prohibitin reduces mitochondrial free radical production and protects brain cells from different injury modalities. J Neurosci 32:583–592

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  68. Cox AG, Brown KK, Arner ES, Hampton MB (2008) The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation. Biochem Pharmacol 76:1097–1109

    Article  CAS  PubMed  Google Scholar 

  69. Zhao C, Ling Z, Newman MB, Bhatia A, Carvey PM (2007) TNF-alpha knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice. Neurobiol Dis 26:36–46

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  70. Bessler H, Djaldetti R, Salman H, Bergman M, Djaldetti M (1999) IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson’s disease. Biomed Pharmacother 53:141–145

    Article  CAS  PubMed  Google Scholar 

  71. Eberhardt O, Schulz JB (2003) Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson’s disease. Toxicol Lett 139:135–151

    Article  CAS  PubMed  Google Scholar 

  72. Singh AK, Tiwari MN, Prakash O, Singh MP (2012) A current review of cypermethrin-induced neurotoxicity and nigrostriatal dopaminergic neurodegeneration. Curr Neuropharmacol 10:64–71

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The Department of Biotechnology (DBT), New Delhi, India is sincerely acknowledged for providing the financial support (BT/PR14382/MED/12/474/2010) to the study. Similarly, the CSIR, New Delhi, India is greatly acknowledged for offering the Junior/Senior Research Fellowship to Sonal Agrawal through the National Eligibility Test and for the financial support (BSC0115; miND) to the part of the study. The institutional communication number of this manuscript is 3110.

Conflict of Interest

There are no actual/potential conflicts of interest.

Author information

Authors and Affiliations

  1. CSIR-Indian Institute of Toxicology Research, Mahatma Gandhi Marg, Post Box-80, Lucknow, 226 001, Uttar Pradesh, India

    Sonal Agrawal, Ashish Singh, Pratibha Tripathi & Mahendra Pratap Singh

  2. Academy of Scientific and Innovative Research (AcSIR), New Delhi, India

    Sonal Agrawal & Mahendra Pratap Singh

  3. CSIR-National Botanical Research Institute, Post Box-436, Rana Pratap Marg, Lucknow, 226 001, Uttar Pradesh, India

    Manisha Mishra & Pradhyumna Kumar Singh

Authors
  1. Sonal Agrawal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ashish Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pratibha Tripathi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Manisha Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pradhyumna Kumar Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mahendra Pratap Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mahendra Pratap Singh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agrawal, S., Singh, A., Tripathi, P. et al. Cypermethrin-Induced Nigrostriatal Dopaminergic Neurodegeneration Alters the Mitochondrial Function:A Proteomics Study. Mol Neurobiol 51, 448–465 (2015). https://doi.org/10.1007/s12035-014-8696-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-014-8696-7

Keywords

Search

Navigation